Related Experiment Videos
Recognition of tumor-associated antigens by T-lymphocytes: perspectives for peptide-based vaccines
J C Cerottini1, D Liénard, P Romero
1Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Epalinges, Switzerland.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Corrigendum: Cemiplimab for advanced cutaneous squamous cell carcinoma in kidney transplant recipients.
Frontiers in nephrology·2025
Cemiplimab for advanced cutaneous squamous cell carcinoma in kidney transplant recipients.
Frontiers in nephrology·2023
Advanced cutaneous squamous cell carcinoma of the head in two renal transplanted patients treated with cemiplimab.
Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Prognostic value of serial blood S100B determinations in stage IIB-III melanoma patients: a corollary study to EORTC trial 18952.
European journal of cancer (Oxford, England : 1990)·2010
Sentinel lymph node involvement and a high Breslow index are independent factors of risk for early relapse of melanoma.
Nuklearmedizin. Nuclear medicine·2007
Regional administration of recombinant tumour necrosis factor-alpha in cancer, with special reference to melanoma.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2007
Final results and predictive biomarkers of response and long-term outcomes with first-line pembrolizumab monotherapy in advanced renal cell carcinoma in the phase II KEYNOTE-427 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Navigating uncertainties and evidence gaps in adjuvant therapy for premenopausal women with HR+/HER2- breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Safety and antitumor activity of the first-in-class EGFR-HER3 bispecific antibody-drug conjugate iza-bren (BL-B01D1) in patients with pretreated locally advanced or metastatic breast cancer: a phase 1b study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Adjuvant pembrolizumab for the treatment of clear cell renal cell carcinoma: five-year results from the phase III KEYNOTE-564 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Thymic radiation is associated with worse outcomes in patients with NSCLC.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2-associated high-risk HER2-negative early breast cancer: updated results from the OlympiA phase III trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Associations between endoscopic findings and clinicopathological characteristics in primary gastrointestinal lymphoma: a single-center retrospective study.
Scandinavian journal of gastroenterology·2026
Targeting IKZF2 with molecular glue degraders for cancer immunotherapy.
Drug discovery today·2026